Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Revista Brasileira De Reumatologia|April 17, 2013
Concurrent rheumatoid arthritis and ankylosing spondylitis in one patient: the importance of new classification criteriaValderilio Feijó Azevedo, Pedro Grachinski Buiar
Anais Brasileiros De Dermatologia|June 7, 2013
Risk factors and predictors of psoriatic arthritis in patients with psoriasisValderilio Feijó Azevedo, Pedro Grachinski Buiar
Biologics : Targets & Therapy|August 13, 2014
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonistsPaulo César Martins Urbano, Vanete Thomaz Soccol, Valderilio Feijó Azevedo
Value in Health Regional Issues|April 29, 2018
Potential Regulatory and Commercial Environment for Biosimilars in Latin AmericaValderilio Feijó Azevedo, Erik Sandorff, Brian Siemak, et al.
Revista Brasileira De Reumatologia|January 19, 2011
Occurrence of fibromyalgia in patients with ankylosing spondylitisValderilio Feijó Azevedo, Eduardo dos Santos Paiva, Lúcio Ricardo Hiurko Felippe, et al.
International Journal of Rheumatology|April 11, 2014
Allopurinol, benzbromarone, or a combination in treating patients with gout: analysis of a series of outpatientsValderilio Feijó Azevedo, Pedro Grachinski Buiar, Laura Helena Giovanella, et al.
Clinical Rheumatology|November 27, 2012
Rituximab-induced regression of CREST-related calcinosisDayane Raquel de Paula, Fabiane Barbero Klem, Pedro Gabriel Lorencetti, et al.
Einstein (Sao Paulo, Brazil)|September 20, 2018
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian marketMorton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health systemValderilio Feijó Azevedo, Chayanne N Rossetto, Pedro G Lorencetti, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 31, 2018
Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?Valderilio Feijó Azevedo, Alejandra Babini, Carlo V Caballero-Uribe, et al.
Pageof 3